share_log

Vertex Pharmaceuticals | PX14A6G: Notice of exempt solicitation

Vertex Pharmaceuticals | PX14A6G: Notice of exempt solicitation

福泰制药 | PX14A6G：豁免招标通知
美股SEC公告 ·  04/16 17:01

Moomoo AI 已提取核心信息

Arjuna Capital, on behalf of Vertex Pharmaceuticals Incorporated, has submitted a proxy proposal for the company's 2024 Annual Meeting, urging shareholders to vote 'FOR' Proposal 5. The proposal calls for Vertex to report on pay gaps across race and gender, including median and statistically-adjusted pay gaps. Arjuna Capital argues that disclosing these pay gaps can lead to company performance benefits, such as increased workforce diversity and improved talent retention. Despite Vertex's commitment to publish statistically-adjusted pay gap data in 2025, the company has not agreed to report median pay gap data, which Arjuna Capital believes is essential for a comprehensive view of the company's Inclusion, Diversity, and Equity (ID&E) performance. The proposal highlights that Vertex lags behind peers in pay equity reporting and transparency. The solicitation emphasizes the importance of pay transparency for narrowing pay gaps and enhancing company diversity, which is considered beneficial for the long-term financial interests of shareholders.
Arjuna Capital, on behalf of Vertex Pharmaceuticals Incorporated, has submitted a proxy proposal for the company's 2024 Annual Meeting, urging shareholders to vote 'FOR' Proposal 5. The proposal calls for Vertex to report on pay gaps across race and gender, including median and statistically-adjusted pay gaps. Arjuna Capital argues that disclosing these pay gaps can lead to company performance benefits, such as increased workforce diversity and improved talent retention. Despite Vertex's commitment to publish statistically-adjusted pay gap data in 2025, the company has not agreed to report median pay gap data, which Arjuna Capital believes is essential for a comprehensive view of the company's Inclusion, Diversity, and Equity (ID&E) performance. The proposal highlights that Vertex lags behind peers in pay equity reporting and transparency. The solicitation emphasizes the importance of pay transparency for narrowing pay gaps and enhancing company diversity, which is considered beneficial for the long-term financial interests of shareholders.
阿周那资本代表Vertex Pharmicals Incorporated提交了该公司2024年年会的代理提案，敦促股东对提案5投赞成票。该提案要求Vertex报告不同种族和性别的薪酬差距，包括中位数和经统计调整的薪酬差距。Arjuna Capital认为，披露这些薪酬差距可以带来公司绩效方面的好处，例如增加员工队伍多样性和提高人才保留率。尽管Vertex承诺在2025年发布经统计调整的薪酬差距数据，但该公司尚未同意报告薪酬差距中位数数据，Arjuna Capital认为这对于全面了解公司的包容性、多元化和公平（ID＆E）业绩至关重要。该提案突出表明，Vertex在薪酬公平报告和透明度方面落后于同行。此次招标强调了薪酬透明度对于缩小薪酬差距和增强公司多元化的重要性，这被认为有利于股东的长期财务利益。
阿周那资本代表Vertex Pharmicals Incorporated提交了该公司2024年年会的代理提案，敦促股东对提案5投赞成票。该提案要求Vertex报告不同种族和性别的薪酬差距，包括中位数和经统计调整的薪酬差距。Arjuna Capital认为，披露这些薪酬差距可以带来公司绩效方面的好处，例如增加员工队伍多样性和提高人才保留率。尽管Vertex承诺在2025年发布经统计调整的薪酬差距数据，但该公司尚未同意报告薪酬差距中位数数据，Arjuna Capital认为这对于全面了解公司的包容性、多元化和公平（ID＆E）业绩至关重要。该提案突出表明，Vertex在薪酬公平报告和透明度方面落后于同行。此次招标强调了薪酬透明度对于缩小薪酬差距和增强公司多元化的重要性，这被认为有利于股东的长期财务利益。
有用
没用

该公告为独立文件：

独立文件1

声明：本内容仅用作提供资讯及教育之目的，不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    热议
    美股
    股票代码最新价涨跌幅

    暂无数据

    资讯热榜
    更新时间